F Y Yao

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
  2. doi request reprint Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria
    F Y Yao
    Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Am J Transplant 8:1982-9. 2008
  3. ncbi request reprint Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
    F Y Yao
    Department of Medicine, University of California, San Francisco 94143 0538, USA
    Hepatology 33:1394-403. 2001
  4. ncbi request reprint Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging
    F Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Am J Transplant 7:2587-96. 2007
  5. ncbi request reprint Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
    F Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 34:411-6. 2001
  6. ncbi request reprint Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    F Y Yao
    Department of Transplantation, California Pacific Medical Center, San Francisco 94143 0538, USA
    J Hepatol 33:301-7. 2000
  7. ncbi request reprint Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma
    S D Chao
    Departments of Surgery, University of California, San Francisco, CA, USA
    Am J Transplant 7:1594-600. 2007
  8. ncbi request reprint The role of the interventional radiologist. Transjugular procedures
    N M Bass
    Liver Transplant Program, Division of Gastroenterology and Liver Transplant Program, University of California, San Francisco, San Francisco, California 94143-0538, USA
    Gastrointest Endosc Clin N Am 11:131-61. 2001

Detail Information

Publications8

  1. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
    ..2% and 92.1%, respectively. No patient had HCC recurrence after a median posttransplantation follow-up of 25 months. The only factor predicting treatment failure was pretreatment alpha-fetoprotein >1,000 ng/mL...
  2. doi request reprint Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria
    F Y Yao
    Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Am J Transplant 8:1982-9. 2008
    ....
  3. ncbi request reprint Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival
    F Y Yao
    Department of Medicine, University of California, San Francisco 94143 0538, USA
    Hepatology 33:1394-403. 2001
    ..0005). We conclude that the current criteria for OLT based on tumor size may be modestly expanded while still preserving excellent survival after OLT...
  4. ncbi request reprint Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging
    F Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Am J Transplant 7:2587-96. 2007
    ....
  5. ncbi request reprint Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort
    F Y Yao
    Department of Medicine, Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 34:411-6. 2001
    ..However, the small sample size and the use of a retrospective control cohort preclude drawing definitive conclusions. Expedited OLT remains the only viable treatment for lamivudine nonresponders...
  6. ncbi request reprint Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    F Y Yao
    Department of Transplantation, California Pacific Medical Center, San Francisco 94143 0538, USA
    J Hepatol 33:301-7. 2000
    ..The aim of this study was to evaluate the effectiveness of lamivudine treatment in severely decompensated cirrhosis due to chronic hepatitis B...
  7. ncbi request reprint Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma
    S D Chao
    Departments of Surgery, University of California, San Francisco, CA, USA
    Am J Transplant 7:1594-600. 2007
    ....
  8. ncbi request reprint The role of the interventional radiologist. Transjugular procedures
    N M Bass
    Liver Transplant Program, Division of Gastroenterology and Liver Transplant Program, University of California, San Francisco, San Francisco, California 94143-0538, USA
    Gastrointest Endosc Clin N Am 11:131-61. 2001
    ..This article reviews the current techniques, indications, and complications of these interventional procedures and their role in the management of patients with end-stage liver disease...